Madison Investment Advisors LLC Purchases New Shares in Option Care Health, Inc. (NASDAQ:OPCH)

Madison Investment Advisors LLC purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 178,236 shares of the company’s stock, valued at approximately $4,135,000. Madison Investment Advisors LLC owned approximately 0.10% of Option Care Health as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of OPCH. UMB Bank n.a. grew its stake in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after acquiring an additional 346 shares in the last quarter. Quarry LP grew its stake in shares of Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after acquiring an additional 2,628 shares in the last quarter. Blue Trust Inc. lifted its position in Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock worth $109,000 after purchasing an additional 681 shares during the period. Venturi Wealth Management LLC lifted its position in Option Care Health by 2,621.3% during the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock worth $110,000 after purchasing an additional 4,561 shares during the period. Finally, KBC Group NV lifted its position in Option Care Health by 46.4% during the fourth quarter. KBC Group NV now owns 7,337 shares of the company’s stock worth $170,000 after purchasing an additional 2,324 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms recently weighed in on OPCH. Barrington Research upped their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and increased their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. increased their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, Option Care Health has an average rating of “Moderate Buy” and an average price target of $33.00.

Insider Activity at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.64% of the stock is owned by company insiders.

Option Care Health Stock Up 0.8 %

OPCH stock opened at $34.58 on Friday. The firm has a 50-day moving average price of $31.84 and a 200-day moving average price of $28.35. The stock has a market capitalization of $5.72 billion, a P/E ratio of 29.06, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.85. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.